Dataset
CANDESARTAN CILEXETIL; ESI-QTOF; MS2; CE 20eV; [M-H]-
Chemical Information
| InChI | InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38) |
|---|---|
| SMILES | CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC(C)OC(=O)OC6CCCCC6 |
| InChI Key | GHOSNRCGJFBJIB-UHFFFAOYSA-N |
| Molecular Formula | C33H34N6O6 |
| Exact Mass | 610.254 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-UPAO-UPA00014 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2016-01-19 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| CHEMBL1014 | ChEMBL |
| 12014669 | PubChem: Drugs of the Future |
| CANDESARTAN CILEXETIL | DailyMed |
| 50318907 | BindingDB |
| ATACAND | rxnorm |
| CANDESARTAN CILEXETIL | clinicaltrials |
| ATACAND | clinicaltrials |
| TCV-116 | clinicaltrials |
| HY-17505 | MedChemExpress |
| R85M2X0D68 | FDA SRS |
| 8352 | Guide to Pharmacology |
| 3348 | ChEBI |
| DTXSID5020239 | EPA CompTox Dashboard |
| 475 | DrugCentral |
| J1.640.921I | Nikkaji |
| HMDB0249581 | Human Metabolome Database |
| CANDESARTAN CILEXETIL | rxnorm |
| Candesartan-cilexetil-Atacand | Selleck |
| LSM-1716 | LINCS |
| 145040-37-5 | ACToR |
| 14887395 | PubChem: Thomson Pharma |
| 2540 | PubChem |
| 57582538 | PubChem: Thomson Pharma |
| PD001206 | ProbesDrugs |
| 1985914 | eMolecules |
| SCHEMBL40831 | SureChEMBL |
| CB3209325 | ChemicalBook |
| candesartan cilexetil | DailyMed |
| DB00796 | DrugBank |
| The data in this table is sourced from UniChem at EBI. | |